Stephen S. Y. Lam1 article listing Stephen S. Y. Lam in Nature Communications, indexed by Paperzzz from Crossref and OSF.Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trial Nature Communications